Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fachklinik Hornheide an der Universität Münster
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
age between 18 and 70
histologically proven malignant melanoma with advanced inoperable soft tissue metastases
progressive disease upon systemic first-line chemotherapy
2 or more bidimensionally measurable soft tisue lesions
WHO performance status (ECOG) of 2 or more
life expectancy of 8 weeks and more
prior informed consent
You may not be if
participation in other therapy studies
pregnancy or breast feeding
concomitant clinically significant infection
cardiac pacemaker or other medical implants, or implants within the hyperthermia treated region (including a safe distance of 5 cm)
lack of physiological heat sensitivity within the hyperthermia treated region (including a safe distance of 5 cm)
Clareo Health | Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases
